Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database.

ABSTRACT:

Introduction

Although hospitals are key health service providers, their financial ties to drug companies are little understood. We examine non-research pharmaceutical industry payments to English National Health Service (NHS) trusts-hospital groupings providing secondary and tertiary care.

Methods

We extracted data from the industry-run Disclosure UK database, analysing it descriptively and using the Jonckheere-Terpstra test to establish whether a statistically significant time trend existed in the median values of individual payments. We explained payment value and number per trust with random effects models, using selected trust characteristics as predictors.

Results

Drug companies reported paying £60,253,421 to 234 trusts, representing between 90.0% and 92.0% of al

SUBMITTER: Ozieranski P 

PROVIDER: S-EPMC10619808 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature